Septerna, Inc. Announces Board and Executive Compensation Changes
Ticker: SEPN · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1984086
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
Septerna's board shuffled, exec pay tweaked. Keep an eye on strategy shifts.
AI Summary
On July 30, 2025, Septerna, Inc. announced changes to its board of directors and executive compensation. Specifically, the company reported the departure of a director and the election of a new director, along with updates to its compensatory arrangements for certain officers. The filing does not disclose specific names or dollar amounts related to these changes.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes without immediate financial implications.
Key Players & Entities
- Septerna, Inc. (company) — Registrant
- July 30, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 250 East Grand Avenue, South San Francisco, California 94080 (address) — Principal Executive Offices
FAQ
Who departed from Septerna, Inc.'s board of directors?
The filing states there was a departure of a director but does not name the individual.
Who was elected to Septerna, Inc.'s board of directors?
The filing indicates the election of a new director but does not provide their name.
What specific changes were made to executive compensation arrangements?
The filing mentions updates to compensatory arrangements for certain officers but does not detail the specific changes.
What is Septerna, Inc.'s principal executive office address?
Septerna, Inc.'s principal executive offices are located at 250 East Grand Avenue, Suite 65, South San Francisco, California 94080.
What is the SIC code for Septerna, Inc.?
The Standard Industrial Classification (SIC) code for Septerna, Inc. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Septerna, Inc. (SEPN).